Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Evidence-based guidelines released Monday recommend that women with epilepsy avoid taking the antiepileptic drug (AED) valproate during pregnancy. "Good evidence shows that valproate…
NEW YORK (Reuters Health) – New research suggests that use of statin therapy in postmenopausal women with coronary artery disease may reduce the risk of atrial fibrillation. The…
NEW YORK (Reuters Health) – The presence of multiple single nucleotide polymorphisms (SNPs) associated with increased prostate cancer risk, coupled with a positive family history, accurately identify men…
NEW YORK (Reuters Health) – A recent prospective study disproves earlier observations that non-steroidal anti-inflammatory drugs (NSAIDS) prevent Alzheimer dementia (AD). At best, NSAIDS may delay its onset,…
NEW YORK (Reuters Health) – Vilazodone, the first of a new class of antidepressants known as indolalkylamines, has been shown in a phase III trial to be effective…
NEW YORK (Reuters Health) – Elderly patients with Alzheimer’s disease treated with second-generation antipsychotics should be monitored closely for weight gain and dyslipidemia, according to an analysis of…
NEW YORK (Reuters Health) – Three milligrams of melatonin at bedtime can effectively treat sleep problems in children with autistic spectrum disorder or fragile X syndrome or both,…
NEW YORK (Reuters Health) – Certain women may be at risk of developing systemic lupus erythematosus (SLE) when they start taking combined oral contraceptives, according to investigators at…
NEW YORK (Reuters Health) – Use of valproate during pregnancy compared with other antiepileptic drugs is associated with reduced cognitive function in offspring at 3 years of age,…
NEW YORK (Reuters Health) – Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, is a safe and effective treatment for hot flushes in postmenopausal women, according to a report in the…
